GENEVA: The WHO and pharmaceuticals giant Pfizer on Friday announced a deal for up to 40 million initial doses of the Pfizer-BioNTech Covid-19 vaccine for poorer countries, through Covax global pool.

World Health Organization director-general Tedros Adhanom Ghebreyesus said Covax — the globally-pooled coronavirus vaccine procurement and equitable distribution effort — could begin delivering doses in February.

“I’m glad to announce that Covax has signed an agreement with Pfizer-BioNTech for up to 40 million doses of its Covid-19 vaccine,” he told a press conference in Geneva.

Covax aims to secure enough Covid-19 vaccines this year for the most vulnerable 20 percent in every country, rich or poor.

In Covax, funding is covered for the 92 lower- and lower-middle income economies involved, while for richer countries, it operates as a back-up insurance policy.

Aimed at pooling the risk and rewards, Covax has struck agreements with manufacturers for two billion vaccine doses, and has secured options on a further billion.

It is co-led by the WHO as well as Gavi, the Vaccine Alliance, and CEPI, the Coalition for Epidemic Preparedness Innovations.

“Vaccines are giving us all hope of ending the pandemic and getting the economy on the road to recovery,” said Tedros.